Mar 25, 2025 · Dapagliflozin (Farxiga) is an SGLT2 inhibitor that is mainly used alongside diet and exercise to help treat type 2 diabetes, but it is also used in the treatment of heart failure.

Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes.

Oct 1, 2025 · It works in the kidneys to prevent absorption of glucose (blood sugar). This helps lower the blood sugar level. Dapagliflozin does not help patients who have insulin-dependent or type 1 …

Dapagliflozin is in a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It lowers blood sugar by causing the kidneys to get rid of more glucose in the urine.

DAPAGLIFLOZIN (DAP a gli FLOE zin) treats type 2 diabetes. It works by helping your kidneys remove sugar (glucose) from your blood through the urine, which decreases your blood sugar. It may also be …

Find patient medical information for dapagliflozin propanediol oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Jun 28, 2024 · DAPAGLIFLOZIN TABLETS are indicated: • To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults …

Find out how dapagliflozin treats type 2 diabetes, heart failure and chronic kidney disease, and how to take it. NHS medicines information on dapagliflozin – what it's used for, side effects, dosage and who …

Dapagliflozin (Farxiga) is an oral prescription medication used to improve blood glucose (glycemia) control in adults with type 2 diabetes. Side effects, drug interactions, dosing, storage, and pregnancy …

View dapagliflozin information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, contra-indications and important safety information.